BASF Pushes Product Pipeline Forward While AI Jitters Drag Shares Lower

BASF packed a week with regulatory wins, partnership agreements and a raised profit target — then watched its stock slide 2.9% as a global selloff in AI and semiconductor names swept through Frankfurt. The drop outpaced the DAX, which shed 1.92% on the same day, according to dpa. Reuters pinned the market-wide weakness on worries about AI stocks and possible restrictions on AI data centres, leaving investors to weigh whether BASF's operational momentum can hold up in a hostile trading environment.

A Regulatory Green Light Down Under

The most concrete corporate news came Wednesday, when BASF announced that Australia's APVMA had approved Luximax for use on Australian canola. According to the company, it is the first Group 30 herbicide registered for canola in the country — a tangible regulatory step rather than a mere intention.

That approval sits alongside an award handed out Thursday. BASF, together with Stellantis and L&L Products, received an SPE Automotive Innovation Award for a composite tunnel reinforcement developed for the 2027 Jeep Grand Cherokee, putting a specific vehicle application in the spotlight.

Projects at Very Different Stages of Maturity

Not every announcement carries the same weight, and the company's own disclosures make the distinction clear. The Australian registration is granted. For the planned electronic-materials production site in Nanjing, BASF signed an investment agreement with the Nanjing Jiangbei New Area on Tuesday, with commissioning targeted for the end of 2028. A letter of intent inked with ParagonCorp on Tuesday goes no further than exploring possible cooperation in scientifically grounded cosmetic innovation.

Should investors sell immediately? Or is it worth buying BASF?

That ladder of readiness matters for anyone trying to price the news into expectations. A signed investment agreement still requires execution; a letter of intent requires a positive outcome from the review before any joint venture takes shape. Should the Nanjing site come online as planned, it could strengthen the longer-term story — delays would push back the point at which investors can count on contributions from the new facility. Likewise, the ParagonCorp thesis weakens if the review yields no concrete projects.

Portfolio Housekeeping in Chile

On the portfolio side, BASF agreed to sell its Palatal business in Chile to ALTA Performance Materials. The company said the divestment serves its push to concentrate on core chemical operations. Completion remains subject to customary conditions, including regulatory approvals.

Evonik Stands Its Ground

Resistance at Evonik remains a live theme in BASF's proposed takeover of the target. Evonik rejected BASF's improved offer just over a week ago but permitted a purely informational, confidential exchange. On Thursday, interim chief Claus Rettig reaffirmed the company's claim to independence in an interview with the Frankfurter Allgemeine Zeitung.

The Earnings Yardstick

Underpinning the whole picture is the raised guidance: BASF lifted its full-year 2026 EBITDA forecast to between EUR 7.4 billion and EUR 7.8 billion. For the third quarter of 2026, the company reported revenue of EUR 16.4 billion and EBITDA before special items of EUR 1.6 billion.

BASF at a turning point? This analysis reveals what investors need to know now.

Not everyone was won over by the upgrade. According to a dpa-AFX report dated 28 October, several analysts judged the fourth-quarter outlook to be below market expectations — a reminder that the headline number alone does not settle the debate.

What Comes Next

Two dates now anchor the calendar. BASF has scheduled press releases for 11 November following the inauguration of its MDI investment in Geismar. The Capital Markets Day follows on 23 and 24 November. Between those milestones, progress at Nanjing and the outcome of the ParagonCorp review stand out as potential catalysts — provided the company converts its pipeline into earnings and delivers on the corridor it has set for itself.

Ad

BASF Stock: New Analysis - 7 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...